• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

存档的甲状腺乳头状癌标本中 miRNA 和内参基因的稳定性不同。

Different stability of miRNAs and endogenous control genes in archival specimens of papillary thyroid carcinoma.

机构信息

Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio Av. 7, 10257, Vilnius, Lithuania.

Institute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, 50161, Kaunas, Lithuania.

出版信息

Mol Med. 2020 Nov 5;26(1):100. doi: 10.1186/s10020-020-00218-7.

DOI:10.1186/s10020-020-00218-7
PMID:33153429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7643475/
Abstract

BACKGROUND

The most popular miRNA quantitation technique is RQ-PCR with relative gene expression method that requires an endogenous control (EC) gene for data normalization. However, there are insufficient data and selection criteria on the most suitable ECs for miRNA expression studies in many cancer types including papillary thyroid carcinoma (PTC). Therefore, in this study we evaluated the impact of chosen EC and archival formalin-fixed, paraffin-embedded (FFPE) PTC tissue age on estimated target miRNA expression.

METHODS

RQ-PCR was used to determine expression levels of five miRNAs (miR-146b, miR-222, miR-21, miR-221 and miR-181b) and three different endogenous controls (RNU48, let-7a, miR-16), which were used to normalize the data. In total, 400 FFPE PTC tissues were analyzed that have been stored from 1 to 15 years.

RESULTS

The stability of commonly used ECs RNU48 and let-7a significantly differs from the stability of target miRNA in archival FFPE PTC tissues. Moreover, these differences have a great impact on miRNA expression results when FFPE tissue samples have been stored for a different period of time.

CONCLUSIONS

It is important to select an ECs not only stable in the tissue of interest but also with similar stability to target miRNA, especially when working with samples of different age.

摘要

背景

最流行的 miRNA 定量技术是 RQ-PCR 相对基因表达法,该方法需要内参(EC)基因进行数据归一化。然而,在许多癌症类型包括甲状腺乳头状癌(PTC)中,miRNA 表达研究中最适合的 EC 数据不足,选择标准也不明确。因此,在这项研究中,我们评估了所选 EC 和存档福尔马林固定、石蜡包埋(FFPE)PTC 组织年龄对估计的靶 miRNA 表达的影响。

方法

使用 RQ-PCR 测定 5 种 miRNA(miR-146b、miR-222、miR-21、miR-221 和 miR-181b)和 3 种不同内参(RNU48、let-7a、miR-16)的表达水平,以归一化数据。总共分析了 400 个 FFPE PTC 组织,这些组织的储存时间从 1 年到 15 年不等。

结果

常用 ECs RNU48 和 let-7a 的稳定性与 FFPE PTC 组织中靶 miRNA 的稳定性显著不同。此外,当 FFPE 组织样本储存时间不同时,这些差异对 miRNA 表达结果有很大影响。

结论

选择不仅在感兴趣的组织中稳定,而且与靶 miRNA 具有相似稳定性的 ECs 非常重要,特别是在处理不同年龄的样本时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3358/7643475/193cbe13a9bb/10020_2020_218_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3358/7643475/5ab9ca646811/10020_2020_218_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3358/7643475/193cbe13a9bb/10020_2020_218_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3358/7643475/5ab9ca646811/10020_2020_218_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3358/7643475/193cbe13a9bb/10020_2020_218_Fig2_HTML.jpg

相似文献

1
Different stability of miRNAs and endogenous control genes in archival specimens of papillary thyroid carcinoma.存档的甲状腺乳头状癌标本中 miRNA 和内参基因的稳定性不同。
Mol Med. 2020 Nov 5;26(1):100. doi: 10.1186/s10020-020-00218-7.
2
Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.Lin28A/let-7a/c-Myc 通路在甲状腺乳头状癌生长和恶性行为中的作用。
Med Sci Monit. 2018 Dec 9;24:8899-8909. doi: 10.12659/MSM.908628.
3
MicroRNA Profiling in Papillary Thyroid Cancer.甲状腺乳头状癌中的 microRNA 谱分析。
Int J Mol Sci. 2024 Aug 29;25(17):9362. doi: 10.3390/ijms25179362.
4
MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting in Human Papillary Thyroid Cancer.miR-146b-3p 通过直接靶向在人甲状腺乳头状癌中促进细胞转移。
Thyroid. 2018 Dec;28(12):1627-1641. doi: 10.1089/thy.2017.0626. Epub 2018 Oct 27.
5
Clinical Impact of Androgen Receptor-Suppressing miR-146b Expression in Papillary Thyroid Cancer Aggressiveness.在甲状腺乳头状癌侵袭性中,雄激素受体抑制 miR-146b 表达的临床影响。
J Clin Endocrinol Metab. 2023 Oct 18;108(11):2852-2861. doi: 10.1210/clinem/dgad279.
6
Identification of key genes and miRNAs markers of papillary thyroid cancer.鉴定甲状腺乳头状癌的关键基因和 miRNA 标志物。
Biol Res. 2018 Nov 10;51(1):45. doi: 10.1186/s40659-018-0188-1.
7
Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues.使用福尔马林固定石蜡包埋组织,比较甲状腺乳头状癌与结节性甲状腺肿中微小RNA的差异表达。
Endocr Pathol. 2007 Fall;18(3):163-73. doi: 10.1007/s12022-007-0023-7.
8
Down-regulation of the human major histocompatibility complex class I chain-related gene A (MICA) and its receptor is mediated by microRNA-146b-5p and is a potential mechanism of immunoediting in papillary thyroid carcinoma.人主要组织相容性复合体 I 类链相关基因 A(MICA)及其受体的下调受 microRNA-146b-5p 介导,是甲状腺乳头状癌免疫编辑的潜在机制。
Exp Mol Pathol. 2020 Apr;113:104379. doi: 10.1016/j.yexmp.2020.104379. Epub 2020 Jan 11.
9
and 51 as diagnostic biomarkers for papillary thyroid carcinoma in formalin-fixed paraffin-embedded tissues.并将 51 项作为福尔马林固定石蜡包埋组织中甲状腺乳头状癌的诊断生物标志物。
Pharmazie. 2020 Jun 1;75(6):266-270. doi: 10.1691/ph.2020.0335.
10
Mapping the Molecular Basis and Markers of Papillary Thyroid Carcinoma Progression and Metastasis Using Global Transcriptome and microRNA Profiling.利用全转录组和 microRNA 谱分析绘制甲状腺乳头状癌进展和转移的分子基础和标志物。
OMICS. 2020 Mar;24(3):148-159. doi: 10.1089/omi.2019.0188. Epub 2020 Feb 19.

引用本文的文献

1
A new perspective on diagnostic strategies concerning the potential of saliva-based miRNA signatures in oral cancer.关于基于唾液的 miRNA 特征在口腔癌中的潜在应用的诊断策略的新视角。
Diagn Pathol. 2024 Nov 16;19(1):147. doi: 10.1186/s13000-024-01575-1.
2
Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer.基质金属蛋白酶9/微小RNA - 145比值:连接甲状腺癌中的基因组和免疫变异性
Biomedicines. 2023 Nov 1;11(11):2953. doi: 10.3390/biomedicines11112953.
3
Farnesoid X receptor regulates lung macrophage activation and injury following nitrogen mustard exposure.

本文引用的文献

1
MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.微小RNA-221,一种甲状腺乳头状癌复发的潜在预后生物标志物。
World J Surg Oncol. 2017 Jan 7;15(1):11. doi: 10.1186/s12957-016-1086-z.
2
Differential long-term stability of microRNAs and RNU6B snRNA in 12-20 year old archived formalin-fixed paraffin-embedded specimens.12至20岁存档福尔马林固定石蜡包埋标本中微小RNA和RNU6B小核RNA的差异长期稳定性
BMC Cancer. 2017 Jan 6;17(1):32. doi: 10.1186/s12885-016-3008-4.
3
Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers.
法尼醇 X 受体调节氮芥暴露后肺巨噬细胞的激活和损伤。
Toxicol Appl Pharmacol. 2022 Nov 1;454:116208. doi: 10.1016/j.taap.2022.116208. Epub 2022 Aug 23.
4
Reference Genes for qPCR-Based miRNA Expression Profiling in 14 Human Tissues.用于 qPCR 检测 miRNA 表达谱的 14 个人类组织参考基因。
Med Princ Pract. 2022;31(4):322-332. doi: 10.1159/000524283. Epub 2022 Mar 30.
5
ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression Binding HuR and Repressing FSCN1/AKT Axis.ADORA2A-AS1通过结合HuR并抑制FSCN1/AKT轴来限制肝细胞癌进展。
Front Oncol. 2021 Oct 18;11:754835. doi: 10.3389/fonc.2021.754835. eCollection 2021.
6
MicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Matched Analysis.基于微小RNA的风险评分预测分化型甲状腺癌患者放射性碘消融后的肿瘤进展:一项倾向评分匹配分析
Cancers (Basel). 2021 Sep 16;13(18):4649. doi: 10.3390/cancers13184649.
BRAF V600E突变及微小RNA表达与甲状腺乳头状癌中央区淋巴结转移的相关性:一项来自四个内分泌外科中心的前瞻性研究
Thyroid. 2016 Apr;26(4):532-42. doi: 10.1089/thy.2015.0378. Epub 2016 Mar 7.
4
MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.MiR-9和miR-21作为甲状腺乳头状癌复发的预后生物标志物。
Clin Exp Metastasis. 2015 Aug;32(6):521-30. doi: 10.1007/s10585-015-9724-3. Epub 2015 May 26.
5
MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.miR-222 和 miR-146b 是复发性甲状腺乳头状癌的组织和循环生物标志物。
Cancer. 2013 Dec 15;119(24):4358-65. doi: 10.1002/cncr.28254. Epub 2013 Oct 28.
6
Expression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.在中国患者中,甲状腺乳头状癌中 miRNA 的表达与 BRAF 突变及临床病理特征相关。
Int J Endocrinol. 2013;2013:128735. doi: 10.1155/2013/128735. Epub 2013 Apr 11.
7
Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.综合 microRNA 表达谱分析鉴定滤泡型甲状腺癌的新型标志物。
Thyroid. 2013 Nov;23(11):1383-9. doi: 10.1089/thy.2012.0632. Epub 2013 Sep 19.
8
microRNAs and thyroid cancer: biological and clinical significance (Review).微小 RNA 与甲状腺癌:生物学及临床意义(综述)。
Int J Mol Med. 2012 Nov;30(5):991-9. doi: 10.3892/ijmm.2012.1089. Epub 2012 Aug 8.
9
MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.微 RNA 表达谱有助于从细针抽吸细胞中区分良性结节和甲状腺乳头状癌。
Eur J Endocrinol. 2012 Sep;167(3):393-400. doi: 10.1530/EJE-12-0400. Epub 2012 Jun 22.
10
Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA/RNA extraction techniques.石蜡块中的核酸数量和质量:定义最佳固定、处理和 DNA/RNA 提取技术。
Exp Mol Pathol. 2012 Feb;92(1):33-43. doi: 10.1016/j.yexmp.2011.09.013. Epub 2011 Sep 21.